K1Z0 Stock Overview
A medical technology company, engages in the development of products and solutions for the treatment of chronic migraine and rhinitis in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Chordate Medical Holding AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 3.63 |
| 52 Week High | SEK 13.55 |
| 52 Week Low | SEK 0.05 |
| Beta | 0.85 |
| 11 Month Change | 74.86% |
| 3 Month Change | 81.50% |
| 1 Year Change | -37.95% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -84.55% |
Recent News & Updates
Recent updates
Shareholder Returns
| K1Z0 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 26.5% | -0.6% | 1.1% |
| 1Y | -37.9% | 10.5% | 18.9% |
Return vs Industry: K1Z0 underperformed the German Medical Equipment industry which returned 10.5% over the past year.
Return vs Market: K1Z0 underperformed the German Market which returned 18.9% over the past year.
Price Volatility
| K1Z0 volatility | |
|---|---|
| K1Z0 Average Weekly Movement | 26.5% |
| Medical Equipment Industry Average Movement | 5.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: K1Z0's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: K1Z0's weekly volatility has decreased from 958% to 27% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 3 | Anders Weilandt | www.chordate.com |
Chordate Medical Holding AB (publ), a medical technology company, engages in the development of products and solutions for the treatment of chronic migraine and rhinitis in Sweden. It offers Ozilia, a neuromodulation and drug-free treatment technology for chronic migraine and chronic rhinitis. The company was founded in 2005 and is based in Kista, Sweden.
Chordate Medical Holding AB (publ) Fundamentals Summary
| K1Z0 fundamental statistics | |
|---|---|
| Market cap | €3.55m |
| Earnings (TTM) | -€2.43m |
| Revenue (TTM) | €276.38k |
12.8x
P/S Ratio-1.5x
P/E RatioIs K1Z0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| K1Z0 income statement (TTM) | |
|---|---|
| Revenue | SEK 3.16m |
| Cost of Revenue | SEK 699.34k |
| Gross Profit | SEK 2.46m |
| Other Expenses | SEK 30.29m |
| Earnings | -SEK 27.82m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 05, 2024
| Earnings per share (EPS) | -28.50 |
| Gross Margin | 77.88% |
| Net Profit Margin | -880.12% |
| Debt/Equity Ratio | 0% |
How did K1Z0 perform over the long term?
See historical performance and comparison